Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats

Ken Iwata, Kazumi Matsuda, Yuji Kurosaki, Taiji Nakayama, Hiroshi Nakajima, Toshikiro Kimura

Research output: Contribution to journalArticlepeer-review


The disposition of adenosine 5′-phosphosulfate (APS), an endogenous nucleotide, was investigated in rats. The degradation of APS in rat plasma was very rapid. APS was degraded in rat plasma to AMP and ATP, and these nucleotides were further degraded through adenosine. The degradation kinetics was examined. For the in vivo study, the method to protect APS front degradation in blood was examined, and it was found that the addition of EDTA to APS-containing blood and storage at 4 °C can protect against APS degradation. After intravenous bolus injection, APS in plasma declined rapidly and the rate of elimination was dose-dependent: the biological half-life was about 2s at the dose of 0.3mg/kg and was longer at 3 mg/kg. When APS was administered by intravenous infusion, the plasma level rapidly reached a steady-state, which then rapidly declined after the infusion was stopped. The total body clearance of APS could not be fully explained by metabolism in plasma or glomerular filtration, therefore the contribution of other elimination processes to the total body clearance was suggested.

Original languageEnglish
Pages (from-to)438-443
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Issue number3
Publication statusPublished - Mar 1996


  • APS
  • Adenosine 5′-phosphosulfate
  • Kinetic analysis
  • Plasma degradation
  • Rat

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science


Dive into the research topics of 'Disposition of intravenously administered adenosine 5′-phosphosulfate (APS) in rats'. Together they form a unique fingerprint.

Cite this